多中心评估PET显像中活性渗漏的发生频率与影响,并纳入皮肤吸收剂量的微观建模
该多中心回顾性研究纳入10个显像中心的1000例PET/CT患者,量化注射部位残留活性并采用蒙特卡罗方法模拟皮肤微解剖吸收剂量。结果显示,仅6/1000例注射部位活性超过370 kBq,平均34 kBq(占注射活性的0.008%);外推至470 MBq全量渗漏时表皮吸收剂量低于1 Gy,为确定性皮肤反应所需剂量的二分之一。
要点
- 1000例中仅6例注射部位活性超过370 kBq,无超过1.7 MBq者。
- 460例注射部位活性可肉眼识别,但定量平均仅34 kBq(占注射活性0.008%)。
- 外推470 MBq渗漏时表皮剂量低于1 Gy,真皮对β粒子起屏蔽作用。
核心结论
- 采用定量活性测量标准而非肉眼判断时,PET注射渗漏的发生频率显著低于既往发表数据。
- 渗漏所致表皮浅层剂量因β粒子在真皮内吸收而可能显著低于既往报道。
研究设计与样本
- 回顾性多中心研究,来自10个显像中心共1000例PET/CT患者研究,各中心连续纳入注射部位在视野内的患者。
- 记录放射性药物、注射活性、注射与显像时间、注射部位及注射方法,由感兴趣体积计算注射部位净活性。
- 基于一例轻度渗漏患者的实际几何结构进行蒙特卡罗图像吸收剂量计算,模拟皮肤微解剖中皮下脂肪、真皮与表皮的活性分布,并采用多个皮下脂肪与真皮浓度比进行模拟。
主要发现
- 1000例中仅6例注射部位活性超过370 kBq(10 μCi),无活性超过1.7 MBq(45 μCi)者。
- 1000例中460例注射部位活性可清晰肉眼识别,但定量评估平均活性仅34 kBq(0.9 μCi),占注射活性的0.008%。
- 外推至470 MBq全量渗漏的模拟计算显示,表皮假设吸收剂量低于1 Gy,为确定性皮肤反应所需剂量的二分之一。
- 剂量分布分析显示真皮对辐射敏感的表皮起β屏蔽作用;真皮屏蔽对低能18F正电子高度有效,对较高能68Ga正电子效果较差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There has been significant recent interest in understanding both the frequency of nuclear medicine injection infiltration and the potential for negative impact, including skin injury. However, no large-scale study has yet correlated visualized injection site activity with actual activity measurement of an infiltrate. Additionally, current skin dosimetry approaches lack sufficient detail to account for critical factors that impact the dose to the radiosensitive epidermis. Methods: From 10 imaging sites, 1,000 PET/CT patient studies were retrospectively collected. At each site, consecutive patients with the injection site in the field of view were used. The radiopharmaceutical, injected activity, time of injection and imaging, injection site, and injection method were recorded. Net injection site activity was calculated from volumes of interest. Monte Carlo image-based absorbed dose calculations were performed using the actual geometry from a patient with a minor infiltration. The simulation model used an activity distribution in the skin microanatomy based on known properties of subcutaneous fat, dermis, and epidermis. Simulations using several subcutaneous fat-to-dermis concentration ratios were performed. Absorbed dose to the epidermis, dermis, and fat were calculated along with relative γ- and β-contributions, and these findings were extrapolated to a hypothetical worst-case (470 MBq) full-injection infiltration. Results: Only 6 of 1,000 patients had activity at the injection site in excess of 370 kBq (10 μCi), with no activities greater than 1.7 MBq (45 μCi). In 460 of 1,000 patients, activity at the injection site was clearly visualized. However, quantitative assessment of activities averaged only 34 kBq (0.9 μCi), representing 0.008% of the injected activity. Calculations for the extrapolated 470-MBq infiltration resulted in a hypothetical absorbed dose to the epidermis of below 1 Gy, a factor of 2 lower than what is required for deterministic skin reactions. Analysis of the dose distribution demonstrates that the dermis acts as a β-shield for the radiation-sensitive epidermis. Dermal shielding is highly effective for low-energy 18F positrons but less so with the higher-energy positrons of 68Ga. Conclusion: When quantitative activity measurement criteria are used rather than visual, the frequency of PET infiltration appears substantially below frequencies previously published. Shallow doses to the epidermis from infiltration events are also likely substantially lower than previously reported because of absorption of β-particles in the dermis.
引用
- Sunderland JJ, Graves SA, York DM, et al. Multicenter Evaluation of Frequency and Impact of Activity Infiltration in PET Imaging, Including Microscale Modeling of Skin-Absorbed Dose. J Nucl Med. 2023. PMID: 37230534. doi:10.2967/jnumed.123.265891
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。